EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 66 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,892,000 | -2.3% | 1,092,394 | +15.2% | 1.12% | -49.4% |
| Q2 2020 | $9,099,000 | +95.7% | 947,852 | +38.6% | 2.22% | +246.5% |
| Q1 2020 | $4,650,000 | -63.2% | 683,828 | -19.3% | 0.64% | -65.3% |
| Q4 2019 | $12,625,000 | +45.4% | 847,284 | 0.0% | 1.85% | +75.7% |
| Q3 2019 | $8,685,000 | -3.3% | 847,284 | 0.0% | 1.05% | +3.6% |
| Q2 2019 | $8,981,000 | +17.4% | 847,284 | +54.8% | 1.02% | -0.8% |
| Q1 2019 | $7,651,000 | +37.6% | 547,284 | 0.0% | 1.02% | +38.1% |
| Q4 2018 | $5,560,000 | – | 547,284 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |